CELESTICA INC (CLS.CA) Fundamental Analysis & Valuation

TSX:CLS • CA15101Q2071

Current stock price

486.28 CAD
+33.21 (+7.33%)
Last:

This CLS.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CLS.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CLS was profitable.
  • In the past year CLS had a positive cash flow from operations.
  • CLS had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CLS had a positive operating cash flow.
CLS.CA Yearly Net Income VS EBIT VS OCF VS FCFCLS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • CLS has a Return On Assets of 11.54%. This is amongst the best in the industry. CLS outperforms 100.00% of its industry peers.
  • CLS has a better Return On Equity (37.56%) than 100.00% of its industry peers.
  • The Return On Invested Capital of CLS (24.36%) is better than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLS is significantly above the industry average of 8.98%.
  • The last Return On Invested Capital (24.36%) for CLS is above the 3 year average (17.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
CLS.CA Yearly ROA, ROE, ROICCLS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • CLS has a Profit Margin of 6.72%. This is in the better half of the industry: CLS outperforms 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of CLS has grown nicely.
  • CLS has a Operating Margin of 7.80%. This is in the better half of the industry: CLS outperforms 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of CLS has grown nicely.
  • With a Gross Margin value of 12.06%, CLS is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
  • CLS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS.CA Yearly Profit, Operating, Gross MarginsCLS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CLS.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLS is creating value.
  • CLS has less shares outstanding than it did 1 year ago.
  • CLS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CLS has an improved debt to assets ratio.
CLS.CA Yearly Shares OutstandingCLS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CLS.CA Yearly Total Debt VS Total AssetsCLS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 7.04 indicates that CLS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of CLS (7.04) is better than 62.50% of its industry peers.
  • CLS has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.69, CLS belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
  • CLS has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • CLS has a Debt to Equity ratio of 0.34. This is comparable to the rest of the industry: CLS outperforms 43.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z 7.04
ROIC/WACC2.84
WACC8.57%
CLS.CA Yearly LT Debt VS Equity VS FCFCLS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • CLS has a Current Ratio of 1.44. This is a normal value and indicates that CLS is financially healthy and should not expect problems in meeting its short term obligations.
  • CLS has a Current ratio (1.44) which is comparable to the rest of the industry.
  • CLS has a Quick Ratio of 1.44. This is a bad value and indicates that CLS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.88, CLS is in line with its industry, outperforming 43.75% of the companies in the same industry.
  • The current and quick ratio evaluation for CLS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS.CA Yearly Current Assets VS Current LiabilitesCLS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. CLS.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.59% over the past year.
  • CLS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.67% yearly.
  • The Revenue has grown by 28.46% in the past year. This is a very strong growth!
  • CLS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.61% yearly.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • CLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.90% yearly.
  • CLS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.42% yearly.
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue Next Year42.21%
Revenue Next 2Y41.08%
Revenue Next 3Y36.42%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS.CA Yearly Revenue VS EstimatesCLS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
CLS.CA Yearly EPS VS EstimatesCLS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

6

4. CLS.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 57.96, which means the current valuation is very expensive for CLS.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLS indicates a rather cheap valuation: CLS is cheaper than 87.50% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CLS to the average of the S&P500 Index (26.78), we can say CLS is valued expensively.
  • A Price/Forward Earnings ratio of 39.02 indicates a quite expensive valuation of CLS.
  • 93.75% of the companies in the same industry are more expensive than CLS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.54, CLS is valued quite expensively.
Industry RankSector Rank
PE 57.96
Fwd PE 39.02
CLS.CA Price Earnings VS Forward Price EarningsCLS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLS is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLS indicates a somewhat cheap valuation: CLS is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 88.08
EV/EBITDA 33.1
CLS.CA Per share dataCLS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CLS has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLS's earnings are expected to grow with 40.90% in the coming years.
PEG (NY)1.19
PEG (5Y)1.33
EPS Next 2Y46.28%
EPS Next 3Y40.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLS.CA Dividend Analysis

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLS.CA Fundamentals: All Metrics, Ratios and Statistics

CELESTICA INC

TSX:CLS (4/10/2026, 7:00:00 PM)

486.28

+33.21 (+7.33%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-22
Inst Owners72.98%
Inst Owner ChangeN/A
Ins Owners0.79%
Ins Owner ChangeN/A
Market Cap55.88B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts82.35
Price Target370.26 (-23.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.27%
Min EPS beat(2)5.95%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)7.73%
Min EPS beat(4)5.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.02%
EPS beat(12)12
Avg EPS beat(12)8.99%
EPS beat(16)16
Avg EPS beat(16)8.6%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)3.86%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)2.5%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.75%
Revenue beat(12)11
Avg Revenue beat(12)3.24%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)0%
PT rev (3m)6.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.01%
EPS NY rev (1m)0%
EPS NY rev (3m)7.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.29%
Valuation
Industry RankSector Rank
PE 57.96
Fwd PE 39.02
P/S 3.26
P/FCF 88.08
P/OCF 61.21
P/B 18.21
P/tB 24.96
EV/EBITDA 33.1
EPS(TTM)8.39
EY1.73%
EPS(NY)12.46
Fwd EY2.56%
FCF(TTM)5.52
FCFY1.14%
OCF(TTM)7.94
OCFY1.63%
SpS149.27
BVpS26.7
TBVpS19.48
PEG (NY)1.19
PEG (5Y)1.33
Graham Number70.99
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
ROICexc(3y)21.34%
ROICexc(5y)16.25%
ROICexgc(3y)28.33%
ROICexgc(5y)22.11%
ROCE(3y)21.66%
ROCE(5y)16.53%
ROICexgc growth 3Y42.82%
ROICexgc growth 5Y38.52%
ROICexc growth 3Y48.19%
ROICexc growth 5Y40.13%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z 7.04
F-Score7
WACC8.57%
ROIC/WACC2.84
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year42.21%
Revenue Next 2Y41.08%
Revenue Next 3Y36.42%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year74.41%
EBIT Next 3Y58.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 7 / 10 to CLS.CA.


What is the valuation status of CELESTICA INC (CLS.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to CELESTICA INC (CLS.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CELESTICA INC?

CELESTICA INC (CLS.CA) has a profitability rating of 8 / 10.


What is the expected EPS growth for CELESTICA INC (CLS.CA) stock?

The Earnings per Share (EPS) of CELESTICA INC (CLS.CA) is expected to grow by 48.55% in the next year.